NanoViricides, Inc. (NASDAQ:NNVC)

BRIEF

published on 05/14/2024 at 12:35, 11 months 19 days ago

NanoViricides annonce une percée dans le traitement du VRS avec le NV-387

NanoViricides NV-387 Innovation Pharmaceutique Traitement Contre Le VRS Recherche Antivirale
PRESS RELEASE

published on 05/14/2024 at 12:30, 11 months 19 days ago

A Novel Broad-Spectrum Antiviral with Activity Against RSV
NanoViricides, Inc. announces complete survival of animals lethally infected with RSV in lungs upon NV-387 oral treatment. Promising antiviral activity shown in study

NV-387 NanoViricides Inc. Antiviral Treatment RSV Infection Lung Infection
BRIEF

published on 05/08/2024 at 12:35, 11 months 25 days ago

NanoViricides Announces Promising Results with NV-387 in Potentially Treating Smallpox and Mpox

NanoViricides NV-387 Tecovirimat Smallpox Mpox
BRIEF

published on 05/08/2024 at 12:35, 11 months 25 days ago

NanoViricides annonce des résultats prometteurs avec le NV-387 dans le traitement potentiel de la variole et de la Mpox

NanoViricides NV-387 Tecovirimat Variole Mvariole
PRESS RELEASE

published on 05/08/2024 at 12:30, 11 months 25 days ago

A Novel Broad-Spectrum Antiviral with Activity Against Smallpox/Mpox
NanoViricides reports NV-387 shows strong orthopoxvirus activity against Smallpox/Mpox via inhalation and skin transmission. Study highlights efficacy in lethal animal models, supporting clinical development potential

NanoViricides NV-387 Clinical Development Orthopoxvirus Antiviral
BRIEF

published on 05/06/2024 at 12:35, 11 months 27 days ago

NanoViricides Reports Promising Results for NV-387 in Treating Influenza A

NanoViricides NV-387 Antiviral Drugs Influenza A H5N1 Bird Flu
BRIEF

published on 05/06/2024 at 12:35, 11 months 27 days ago

NanoViricides rapporte des résultats prometteurs pour le NV-387 dans le traitement de la grippe A

NanoViricides NV-387 Grippe A Médicaments Antiviraux Grippe Aviaire H5N1
PRESS RELEASE

published on 05/06/2024 at 12:30, 11 months 27 days ago

A Novel Broad-Spectrum Antiviral with Activity Against Influenza A
NanoViricides reports strong anti-influenza activity of NV-387, suggesting effectiveness against H5N1 bird flu virus. Results show superior performance to approved drugs. Further studies needed for confirmation

NanoViricides NV-387 Anti-influenza H5N1 Drug
BRIEF

published on 04/30/2024 at 12:35, 1 year ago

NanoViricides Announces Successful Completion of Phase I Clinical Trial for NV-387

NanoViricides NV-387 Phase I Clinical Trial Antiviral Treatment RSV Infection
BRIEF

published on 04/30/2024 at 12:35, 1 year ago

NanoViricides annonce la réussite de l'essai clinique de phase I pour le NV-387

NanoViricides NV-387 Essai Clinique De Phase I Traitement Antiviral Infection Par Le VRS

Published on 05/03/2025 at 03:40, 2 hours 3 minutes ago

Snipp Interactive Announces Delay in Filing Audited Fiscal 2024 Financial Statements
Published on 05/03/2025 at 03:00, 2 hours 43 minutes ago

Vision Marine Technologies Inc. Announces Postponement of Annual Meeting of Shareholders
Published on 05/03/2025 at 02:06, 3 hours 37 minutes ago

Battery X Metals Achieves Pivotal Milestone with Delivery of Next-Generation Lithium-Ion Battery Rebalancing Machine and Announces Exclusive Live Reveal Event
Published on 05/02/2025 at 23:30, 6 hours 13 minutes ago

RE Royalties Announces Fiscal 2024 Year End Results and Highlights
Published on 05/02/2025 at 15:00, 14 hours 43 minutes ago

Newsmax #1 in Cable News for Key Demo Ratings Growth

View all ACCESSWIRE

Published on 05/02/2025 at 19:00, 10 hours 43 minutes ago

PATRIMOINE ET COMMERCE: INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF
Published on 05/02/2025 at 18:55, 10 hours 47 minutes ago

Avolta's Q1 Trading Update Invitation
Published on 05/02/2025 at 18:41, 11 hours 2 minutes ago

Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Published on 05/02/2025 at 18:30, 11 hours 13 minutes ago

Avolta's Full Year 2024 Results Invitation
Published on 05/02/2025 at 18:30, 11 hours 13 minutes ago

Eleving Group announces the first public shareholder meeting

View all EQS

Published on 05/02/2025 at 20:40, 9 hours 3 minutes ago

Rapport Financier Annuel 2024
Published on 05/02/2025 at 17:35, 12 hours 8 minutes ago

Peugeot Invest - Déclaration du nombre d'actions et de droits de vote
Published on 04/30/2025 at 20:31, 2 days 9 hours ago

COMMUNIQUE DE PRESSE - RESULTATS 2024
Published on 04/30/2025 at 19:14, 2 days 10 hours ago

Report de la publication des résultats annuels 2024
Published on 04/30/2025 at 19:14, 2 days 10 hours ago

Solocal - Press Release - Filing of 2024 URD

View all LES ECHOS COMFI WIRE

News